As of 2025-06-13, the Fair Value of Caribou Biosciences Inc (CRBU) is -7.95 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.16 USD, the upside of Caribou Biosciences Inc is -785.31%.
With the market price of 1.16 USD and our fair value calculation, Caribou Biosciences Inc (CRBU) is not a good investment. Investing in CRBU stocks now will result in a potential loss of 785.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -34.31 | -66.92 | -99.42 | -102.07 | -149.10 | -90.36 |
| YoY growth | -46.44% | -95.05% | -48.57% | -2.67% | -46.08% | -47.76% |
| Market Cap (mil) | 107.88 |
| P/E | |
| Forward P/E |
| EPS | -1.59 |
| Avg earnings growth rate | -47.76% |
| TTM earnings | -147.86 |